Related Experiment Video
Updated: Feb 12, 2026
03:47
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.2K
Mobile Technologies for Managing Heart Failure: A Systematic Review and Meta-analysis
Anisleidy Carbo1, Manish Gupta1, Leonardo Tamariz1,2
11 Division of Internal Medicine, GRECC, Veterans Affairs Medical Center , Miami, Florida.
Summary
Mobile health (m-Health) interventions reduced heart failure (HF) related hospital days but increased overall costs. Further research is needed to confirm the cost-effectiveness of m-Health for HF patients.
Area of Science:
- Cardiology
- Digital Health
- Health Services Research
Background:
- Mobile technologies show promise in improving outcomes for heart failure (HF) patients.
- Previous randomized clinical trials (RCTs) suggest potential benefits.
- A comprehensive meta-analysis is needed to evaluate m-Health's broader impact.
Purpose of the Study:
- To evaluate the impact of m-Health interventions on healthcare utilization, mortality, and cost in heart failure patients.
- To synthesize evidence from randomized clinical trials and quasi-experimental studies.
- To assess the effectiveness and cost-effectiveness of m-Health for HF management.
Main Methods:
- A systematic literature search was conducted across major databases (MEDLINE, Cochrane, CINAHL, EMBASE) from 1966 to May 2017.
- Included studies compared m-Health interventions against usual care in HF patients.
- Outcomes assessed included hospital days, admissions, mortality, and costs related to HF and all causes.
Main Results:
- 10 RCTs and 1 quasi-experimental study involving 3,109 patients were included.
- m-Health significantly reduced HF-related hospital days.
- No significant reductions were observed in HF-related admissions, mortality, or total mortality; total costs increased.
Conclusions:
- m-Health effectively reduces heart failure-related hospitalizations.
- Trends suggest potential reductions in mortality and admissions, but overall costs increased.
- Further high-quality studies are required to establish the definitive effectiveness and cost-effectiveness of m-Health interventions for HF.
Related Concept Videos
01:30Heart Failure V: Medical Management
360
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
01:17Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
01:27Heart Failure I: Introduction
951
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
01:22Heart Failure VI: Adjunct Therapies
395
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
01:22Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K